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Xenopus embryos provide a rapid and accessible in vivo model, expressing a plethora of 
endogenous kinase and phosphatase enzymes that control protein phosphorylation, often 
affecting physiological function. Traditionally, detection of protein phosphorylation has been 
achieved by radioisotope phosphate labelling of proteins, sometimes with in vitro assays 
using recombinant proteins, or by site-specific phospho-antibodies.  However, target 
phospho-sites and kinases responsible are often unknown, and use of radioactive isotopes is 
not always desirable. Therefore, as a first step to determining functional significance of 
potential phosphorylation, it is useful to show that a protein can be phosphorylated in vivo in 
Xenopus eggs and/or embryos. This protocol describes a non-radioactive method to visualise 
protein phosphorylation by exposing the protein to the egg/embryo kinase environment and 
observing a difference in protein migration on SDS-PAGE and western blot with and without 
treatment with lamda phosphatase enzyme. Subsequent investigation of the ability of site-
specific phospho-mutant proteins to recapitulate the effect of phosphatase treatment can be 
used to explore the identity of the phosphorylated sites.  Moreover, detection of multiple 
bands of the protein of interest even after phosphatase treatment points to the presence of 
other types of post-translational modifications.  
 
Materials:  
It is essential that you consult the appropriate Material Safety Data Sheets and your 
institution’s Health and Safety Office for proper handling of equipment and hazardous 
material used in this protocol.  
RECIPES: Please see the end of this protocol for recipes indicated by <R>. Additional 
recipes can be found online at http://cshprotocols.cshlp.org.site/recipes 
 
Reagents:  
 Antibodies for western blot – antibody for protein of interest; antibody for loading 
control – e.g. anti-α-tubulin.  
 Embryo lysis buffer <R>. Prepare fresh and hold on ice.  
 Fertilisation and embryo culture reagents; mRNA encoding proteins of interest, – see 
Protocol: Microinjection of mRNAs and Oligonucleotides (Moody 2018). 
 Lamba protein phosphatase kit with enzyme and associated 10x PMP Buffer and 
10mM MnCl2 (e.g. NEB).  
 Protein quantification assay – e.g. BCA assay. 
 Sample buffer with reducing agent for SDS-PAGE.  
 Western blotting reagents – see Protocol: A rapid western blotting method for the 
Xenopus oocyte (Lin-Moshier and Marchant 2013). The gel percentage and 
composition required for optimal separation of phospho-forms by SDS-PAGE will 
depend on the protein of interest.  
Equipment:  
 Centrifuge – benchtop, temperature controlled and chilled to 4°C.  
 Dry ice <optional> Required if freezing embryos prior to protein extraction.  
 Glass pipette with rubber suction – 1x wide bore and 1x narrow bore. 
 Heat block at 70°C.  
 Ice bucket with wet ice. 
 Microcentrifuge tubes – 1.5ml. 
 Micro-injection equipment for Xenopus embryos – see (Moody 2018). 
 Protein quantification equipment.  
 Water bath at 30°C. 
 Western blotting equipment – see (Lin-Moshier and Marchant 2013) 
 
Method: 
This protocol describes a rapid and non-radioactive method to visualise potential in vivo 
phosphorylation of an over-expressed protein of interest in Xenopus embryos. This is 
achieved by comparing migration of embryo extracts after SDS-PAGE and western blotting 
with and without lambda protein phosphatase treatment, avoiding the need for phospho-site 
specific antibodies. This complements in vitro kinase assays with recombinant target protein 
and kinase enzymes, and has the added benefit of utilising the endogenous kinase and 
phosphatase enzymes in the embryo, to allow determination of phosphorylation in vivo at the 
developmentally relevant stage. This method can also be used to demonstrate the importance 
of specific phosphorylation sites by comparing migration of wild-type and mutant versions of 
the protein of interest, where individual or a combination of potential phosphorylation sites 
have been mutated to a non-phosphorylatable amino acid such as Alanine [e.g. (Hardwick 
and Philpott 2015; Hardwick et al. 2016)]. The protocol can be conducted in continuous or 
multiple discrete steps as described below.  
 
Preparation of embryos 
1. Microinject mRNA encoding each protein of interest into a separate dish of one or two 
cell-stage Xenopus embryos, keeping one dish as uninjected control embryos. See (Moody 
2018).  
The amount of mRNA to be injected will require individual optimisation for the protein of 
interest.   
2. Culture embryos to the relevant stage for analysis of the protein of interest.  
3. Carefully transfer 10-15 embryos to a clean 1.5ml microcentrifuge tube using a wide-bore 
glass pipette.  
The number of embryos collected can be altered if larger volumes of protein extract are 
required.  
4. Remove as much of the culture media as possible using a narrow bore glass pipette, and 
either proceed directly to protein extraction stages or snap freeze embryos in dry ice and store 
at -80°C.  
Additional buffer may be removed with a 10µl pipette but take care not to lyse embryos 
prematurely.  
 
Protein extraction and quantification from whole embryos 
This part of the procedure will take approximately 1 hour and should be conducted on ice. 
The protein extracts can be used directly or stored at -20°C. 
 
3. If embryos have previously been frozen, thaw on ice while making up fresh embryo lysis 
buffer and pre-chilling the centrifuge to 4°C.  
4. Homogenise embryos by repeated pipetting in embryo lysis buffer, using 4µl-10µl per 
embryo.  
4µl is suggested per embryo for unstable proteins or proteins expressed at a low level to 
increase total protein concentration in the extract.    
5. Spin at 4°C for 6 minutes at 1200 xg and collect the middle fraction, above the pellet and 
below the lipid layer. 
6. Re-spin the collected fraction at 4°C for 6 minutes at 1200 xg and collect the supernatant 
as the protein extract.  
7. Determine total protein concentration in each extract using a 1µl aliquot – e.g. by BCA 
assay, using manufacturer’s protocol.  
8. <Optional> Conduct SDS-PAGE and western blot with whole embryo protein extract to 
optimise loading amounts required for adequate visualisation and to determine the gel 
conditions for optimal protein separation.  
The total protein amounts required for detection will vary depending on the protein of 
interest and may range from 20-80µg. If protein concentration needs to be increased to 
enable sufficient total protein in the loading volume, embryos can be lysed in a reduced 
volume in step 4.  
Lambda protein phosphatase treatment 
This part of the procedure will take approximately 1.5 hours but can be done in isolation 
using pre-frozen protein extract and prior to SDS-PAGE. The protein phosphatase enzyme is 
very sensitive to temperature so must be stored at -80°C and only defrosted on ice for the 
minimum time possible.  
 
9. Select the amount of total protein from each extract to be used for SDS-PAGE and western 
blot – e.g. by optimisation in step 8.  
10. Set up protein phosphatase reactions (and control reactions without enzyme) on ice, 
according to manufacturer’s instructions, leaving the phosphatase enzyme at -80°C until 
immediately prior to use and then snap freeze on dry ice as soon as possible.  
Lamba protein phosphatase is a Mn2+-dependent protein phosphatase with activity towards 
phosphorylated serine, threonine and tyrosine residues.  
Each protein of interest should have duplicate reactions in a total volume of 20µl; 
phosphatase enzyme is added to one reaction and an equivalent volume of water is added to 
the other.  
Due to glycerol content in the enzyme preparation, keep the concentration of enzyme to less 
than 10%.  
11. Incubate all reactions (with and without phosphatase) at 30°C in a water bath for 1 hour.  
12. Add the required amount of SDS-reducing loading buffer and heat at 70°C for 10 minutes 
on a heat block. 
These samples can be run directly on SDS-PAGE or frozen at -80°C. If samples are stored, 
repeat heat treatment of 70°C for 10 minutes prior to gel loading.  
 
Analysis by SDS-PAGE and western blotting 
13. Separate proteins by SDS-PAGE and western blotting. A loading control such as alpha-
tubulin can be used to demonstrate equal loading.  
The pair of samples for each protein of interest (with and without phosphatase treatment) 
should be run side-by-side to enable direct comparison of migration. An equivalent amount of 
total protein from uninjected embryos can be used to demonstrate antibody specificity for the 
over-expressed protein.  
14. Compare protein migration in the sample lanes to determine the effect of phosphatase 
treatment.  
Wild-type proteins may be phosphorylated on one or more sites, resulting in the appearance 
of a broad band or multiple discrete bands on western blot. The removal of these phosphate 
groups by phosphatase enzyme results in the appearance of a narrower, faster migrating 
band. Example images to illustrate these results are shown in (Hardwick and Philpott 2015; 
Hardwick et al. 2016). Discrete bands may still be present if the protein undergoes 
alternative post-translational modification such as ubiquitination or sumoylation.  
Different SDS-PAGE conditions may be required for optimal separation of protein phospho-
forms and demonstration of phospho-shift with phosphatase treatment. A higher percentage 
gel such as an 18% gel can aid separation. Alternatively, Phos-tag gels may provide superior 
resolution of discrete phospho-forms – see (Horinouchi et al. 2016). If phos-tag gels are 
used, an equivalent amount of MnCl2 must be added to the samples prior to phosphatase 
treatment to bind the EDTA in the embryo lysis buffer. This EDTA will otherwise chelate the 
Mn2+ of the gel and prevent detection of the phospho-forms.  
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Recipes:  
Embryo lysis buffer 
Prepare fresh and store on ice during the protocol. β-glycerophosphate is included as a 
phosphatase inhibitor but additional inhibitors or competitors may be required depending on 
the stability of the phosphorylation status of the protein of interest.   
Reagent Final concentration 
(1X) 
Tris pH8.0 50mM 
NaCl 100mM 
EDTA pH8.0 5mM 
TritonX-100  0.10% 
β-glycerophosphate 50mM 
Protease Inhibitor 
Cocktail (PIC); 
Roche 
1x 
 
